{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:30:58Z","timestamp":1793712658491,"version":"4.6.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The quality of life of women with deep infiltrating endometriosis (DIE) is impaired and may improve with combined oral contraceptives (COCs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare the overall and sexual quality of life of patients diagnosed with DIE with or without associated adenomyosis (AD) with that of healthy controls and determine the influence of a COC containing 2 mg dienogest\/30 \u03bcg ethinyl estradiol on these aspects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled 42 women diagnosed with DIE; 31 diagnosed with DIE + AD by transvaginal ultrasound, and 39 non-AD\/DIE controls. All patients were interviewed regarding pain symptoms (dysmenorrhea, dyspareunia, dyschezia, and dysuria), heavy menstrual bleeding using the Pictorial Blood Loss Assessment Chart, quality of life using the Short Form-36 questionnaire (SF-36), and sexual quality of life using the Sexual Quality of Life-Female questionnaire (SQOL-F) and the Brief Profile of Female Sexual Function (B-PFSF) before starting COCs and after 12 months of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes<\/jats:title><jats:p>There was significant improvement in overall and sexual quality of life after treatment in DIE and DIE + AD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Non-AD\/DIE controls showed significantly higher scores in the B-PFSF, the SQOL-F and the SF-36 questionnaires (P &amp;lt; .05) at baseline versus the other groups. DIE + AD patients showed poorer quality of sexual life and greater intensity in pain symptoms compared with DIE patients. After 12 months of treatment, there was a significant improvement in overall and sexual quality of life in the DIE and DIE + AD groups, with improvement in sexual quality of life being slightly greater in DIE + AD patients compared with DIE patients. Pain symptoms also decreased in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Implications<\/jats:title><jats:p>Patients with DIE + AD showed greater impairment in overall and sexual quality of life compared with patients with isolated DIE which seems to improve with a COC containing 2 mg dienogest\/30 \u03bcg ethinyl estradiol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Strengths &amp; limitations<\/jats:title><jats:p>Strengths include the long-term follow up, assessment of the impact of two associated conditions, and administration of the same COC in all patients. Limitations include the relatively small sample size, and the fact that we did not assess the effectiveness of a flexible extended COC regimen containing 2 mg dienogest\/30 \u03bcg ethinyl estradiol since the groups were different at baseline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients diagnosed with DIE with or without AD have a decreased quality of life which may improve with a COC containing 2 mg dienogest\/30 \u03bcg ethinyl estradiol. Further research is needed to confirm our results.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jsxm.2021.11.015","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T06:01:02Z","timestamp":1640930462000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients with or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study"],"prefix":"10.1093","volume":"19","author":[{"given":"Ana Mar\u00eda","family":"Alcalde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mart\u00ednez-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Rius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camil","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Carmona","sequence":"additional","affiliation":[{"name":"Gynaecology Department, Institute Clinic of Gynaecology, Obstetrics and Neonatology, Hospital Clinic, Universitat de Barcelona, Institut d\u2018Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,31]]},"reference":[{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2023041407171311700_","first-page":"20","article-title":"Long-term efficacy and quality of life associated with bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis","volume":"176","author":"Mingmin","year":"2014","journal-title":"EJOG"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12958-016-0185-6","article-title":"Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease","volume":"14","author":"Puente","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00404-014-3437-8","article-title":"Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study","volume":"291","author":"Leyendecker","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00404-018-4851-0","article-title":"Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study","volume":"298","author":"Sansone","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/aogs.13632","article-title":"Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: a pilot study","volume":"98","author":"Andersson","year":"2019","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humupd\/dmw031","article-title":"Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment","volume":"22","author":"Pluchino","year":"2016","journal-title":"Human Reproduction Update"},{"key":"2023041407171311700_","article-title":"The potential of hormonal contraception to influence female sexuality","volume":"3","author":"De Castro Coelho","year":"2019","journal-title":"Int J Reprod Med"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.fertnstert.2017.07.1165","article-title":"Ethinylestradiol 20 mg\/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial","volume":"108","author":"Harada","year":"2017","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"88334","DOI":"10.18632\/oncotarget.19833","article-title":"Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone","volume":"8","author":"Regidor","year":"2017","journal-title":"Oncotarget"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(01)02951-X","article-title":"Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis","volume":"77","author":"Vercellini","year":"2002","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.fertnstert.2011.01.027","article-title":"Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain","volume":"95","author":"Guzick","year":"2011","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/uog.14806","article-title":"Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group","volume":"46","author":"Van den Bosch","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jmig.2018.04.002","article-title":"Ulipristal acetate improves clinical symptoms in women with adenomyosis and uterine myomas","volume":"25","author":"Gracia","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jmig.2017.06.024","article-title":"Bowel preparation improves the accuracy of transvaginal ultrasound in the diagnosis of rectosigmoid deep infiltrating endometriosis: a prospective study","volume":"24","author":"Ros","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/uog.15955","article-title":"Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International deep endometriosis analysis (IDEA) group","volume":"48","author":"Guerriero","year":"2016","journal-title":"Ultrasound in Obstet Gynecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/uog.14834","article-title":"Transvaginal sonographic features of diffuse adenomyosis in 18-30-years-old nulligravid without endometriosis: association with symptoms","volume":"46","author":"Pinzauti","year":"2015","journal-title":"Ultrasound in Obstet Gynecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1157\/13074369","article-title":"The Spanish version of the short form 36 health survey: a decade of experience and new developments","volume":"19","author":"Vilagut","year":"2005","journal-title":"Gac Sanit"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/09513590701592306","article-title":"Development and validation of a new screening tool for hypoactive sexual desire disorder: the brief profile of female sexual function (B-PFSF)","volume":"23","author":"Rust","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00926230591006502","article-title":"Development of a questionnaire on sexual quality of life in women","volume":"31","author":"Symonds","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.fertnstert.2006.12.077","article-title":"Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis","volume":"88","author":"Razzi","year":"2007","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(01)02951-X","article-title":"Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis","volume":"77","author":"Vercellini","year":"2002","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jsm.12133","article-title":"Women with Deep infiltrating endometriosis: sexual satisfaction, desire, orgasm, and pelvic problem interference with sex","volume":"10","author":"Montanari","year":"2013","journal-title":"J Sex Med"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2018.03.012","article-title":"Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence","volume":"110","author":"Jensen","year":"2018","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","first-page":"193","article-title":"Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo controlled-study","volume":"151","author":"Strowitzki","year":"2010","journal-title":"EJOG"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"2023041407171311700_","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40618-016-0460-6","article-title":"Comparative, open\u2013label prospective study on the quality of life and sexual function of women affected by endometriosis\u2013associated pelvic pain on 2 mg dienogest\/30 \u03bcg ethinyl estradiol continuous or 21\/7 regimen oral contraceptive","volume":"39","author":"Caruso","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 4","key":"2023041407171311700_","first-page":"S17","article-title":"A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido","volume":"89","author":"Oranratanaphan","year":"2006","journal-title":"J Med Assoc Thai"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521007918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521007918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/2\/311\/49877600\/jsm_19_2_311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/2\/311\/49877600\/jsm_19_2_311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T01:37:41Z","timestamp":1700012261000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/19\/2\/311\/6961238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,31]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,31]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.11.015","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2021,12,31]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021, International Society of Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}